Abstract:Finding new therapeutic approaches towards colorectal cancer (CRC) is of increased relevance, as CRC is one of the most common cancers worldwide. CRC standard therapy includes surgery, chemotherapy, and radiotherapy, which may be used alone or in combination. The reported side effects and acquired resistance associated with these strategies lead to an increasing need to search for new therapies with better efficacy and less toxicity. Several studies have demonstrated the antitumorigenic properties of microbiota-derived short-chain fatty acids (SCFAs). The tumor microenvironment is composed by non-cellular components, microbiota, and a great diversity of cells, such as immune cells. The influence of SCFAs on the different constituents of the tumor microenvironment is an important issue that should be taken into consideration, and to the best of our knowledge there is a lack of reviews on this subject. The tumor microenvironment is not only closely related to the growth and development of CRC but also affects the treatment and prognosis of the patients. Immunotherapy has emerged as a new hope, but, in CRC, it was found that only a small percentage of patients benefit from this treatment being closely dependent on the genetic background of the tumors. The aim of this review was to perform an up-to-date critical literature review on current knowledge regarding the effects of microbiota-derived SCFAs in the tumor microenvironment, particularly in the context of CRC and its impact in CRC therapeutic strategies. SCFAs, namely acetate, butyrate, and propionate, have the ability to modulate the tumor microenvironment in distinct ways. SCFAs promote immune cell differentiation, downregulate the expression of pro-inflammatory mediators, and restrict the tumor-induced angiogenesis. SCFAs also sustain the integrity of basement membranes and modulate the intestinal pH. CRC patients have lower concentrations of SCFAs than healthy individuals. Increasing the production of SCFAs through the manipulation of the gut microbiota could constitute an important therapeutic strategy towards CRC due to their antitumorigenic effect and ability of modulating tumor microenvironment.

Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy

New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy

Characterization of the Fatty Acid Metabolism in Colorectal Cancer to Guide Clinical Therapy

Short-chain fatty acids play a positive role in colorectal cancer

Gut microbiome in tumorigenesis and therapy of colorectal cancer

Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy

The role of short-chain fatty acids in cancer prevention and cancer treatment

Gut microbiota modulation: a tool for the management of colorectal cancer

Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action

Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?

Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer

The Roles of Gut Microbiota Metabolites in the Occurrence and Development of Colorectal Cancer: Multiple Insights for Potential Clinical Applications

Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend

Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy

Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis

Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy

Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota

The role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges

The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer